EUVIMEDEUVIMED entdecken
Crossref

Targeting endoplasmic reticulum stress to attenuate cisplatin resistance in non-small cell lung cancer

Semahat Celikten, Zafer Yildirim, Sevim Aydemir, Busra Bara, Eda Dogan, Zuhal Eroglu, Vildan Bozok

Medical Oncology · 2026

DOI: 10.1007/s12032-026-03369-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Semahat Celikten und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Türkiye. Hauptthemen laut MEDLINE: Cisplatin, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lung Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Ege University Scientific Research Projects Coordination.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin-based chemotherapy remains a cornerstone of treatment for advanced non-small cell lung cancer (NSCLC); however, the emergence of chemoresistance severely limits its clinical efficacy. Endoplasmic reticulum (ER) stress and adaptive unfolded protein response (UPR) have been implicated in cancer cell survival and therapy resistance, highlighting modulation of this signalling as a potential therapeutic strategy. In this study, we investigated whether pharmacological induction of endoplasmic reticulum stress via sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA) inhibition could attenuate cisplatin resistance in NSCLC. Using parental and cisplatin-resistant cell lines, we demonstrate that thapsigargin induces transcriptional responses consistent with endoplasmic reticulum stress, characterised by dynamic regulation of GRP78, PERK, XBP1, and ATF4 mRNA expression. Notably, thapsigargin pre-treatment significantly reduced cisplatin IC₅₀ values and decreased resistance indices in resistant cells, indicating attenuation of the resistant phenotype. In addition, SERCA inhibition enhanced apoptotic cell death in selected models and markedly suppressed clonogenic survival and migratory capacity across all cell lines examined. Distinct UPR-related transcriptional patterns were observed between parental and resistant cells, suggesting adaptive remodelling of ER stress signalling during acquisition of cisplatin resistance. Collectively, these findings identify ER calcium homeostasis as a modifiable determinant of platinum responsiveness and support targeting ER stress pathways as a potential adjunct strategy to improve therapeutic efficacy in chemoresistant NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmLung NeoplasmsEndoplasmic Reticulum StressAntineoplastic AgentsHumansEndoplasmic Reticulum Chaperone BiPThapsigarginCell Line, TumorUnfolded Protein ResponseSarcoplasmic Reticulum Calcium-Transporting ATPasesApoptosisActivating Transcription Factor 4

Stichwörter der Autor:innen

ATF4Cisplatin resistanceEndoplasmic reticulum stressGRP78Non-small cell lung cancerPERK signallingThapsigarginXBP1

Substanzen

CisplatinEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanThapsigarginAntineoplastic AgentsSarcoplasmic Reticulum Calcium-Transporting ATPasesActivating Transcription Factor 4

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Türkiye.
  • Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Türkiye. vldnbozok@gmail.com.

Förderung

  • Ege University Scientific Research Projects Coordination

Zitieren

APA

Celikten, S., Yildirim, Z., Aydemir, S., Bara, B., Dogan, E., Eroglu, Z., & Bozok, V. (2026). Targeting endoplasmic reticulum stress to attenuate cisplatin resistance in non-small cell lung cancer. Medical Oncology. https://doi.org/10.1007/s12032-026-03369-5

Vancouver

Celikten S, Yildirim Z, Aydemir S, Bara B, Dogan E, Eroglu Z, et al. Targeting endoplasmic reticulum stress to attenuate cisplatin resistance in non-small cell lung cancer. Medical Oncology. 2026. doi:10.1007/s12032-026-03369-5

BibTeX
@article{Celikten2026,
  author = {Celikten, Semahat and Yildirim, Zafer and Aydemir, Sevim and Bara, Busra and Dogan, Eda and Eroglu, Zuhal and Bozok, Vildan},
  title = {Targeting endoplasmic reticulum stress to attenuate cisplatin resistance in non-small cell lung cancer},
  journal = {Medical Oncology},
  year = {2026},
  doi = {10.1007/s12032-026-03369-5}
}
Kostenlos starten →